InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.014 0.001 (6.67%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 2026 Annual General Meeting - Key Dates 2 Oct 2026 2:15PM $0.018 $0.014 fallen by 22.22%
$39 Change of Director's Interest Notice 23 Sep 2026 1:33PM $0.019 $0.014 fallen by 26.32%
$39 Application for quotation of securities - BOT 23 Sep 2026 1:23PM $0.019 $0.014 fallen by 26.32%
$39 S&P DJI Announces September 2026 Quarterly Rebalance 4 Sep 2026 5:10PM $0.021 $0.014 fallen by 33.33%
$39 Change of Director's Interest Notice 31 Aug 2026 4:01PM $0.021 $0.014 fallen by 33.33%
$39 Notification of cessation of securities - BOT 31 Aug 2026 3:58PM $0.020 $0.014 fallen by 30%
$39 Appendix 4G and Corporate Governance Statement 26 Aug 2026 5:54PM $0.021 $0.014 fallen by 33.33%
$39 Appendix 4E & Annual Report for the Year Ended 30 June 2026 26 Aug 2026 5:53PM $0.021 $0.014 fallen by 33.33%
$39 Notification regarding unquoted securities - BOT 14 Aug 2026 4:05PM $0.022 $0.014 fallen by 34.88%
$39 Application for quotation of securities - BOT 14 Aug 2026 11:08AM $0.021 $0.014 fallen by 33.33%
$39 Notification of cessation of securities - BOT 3 Aug 2026 2:23PM $0.020 $0.014 fallen by 30%
$39 Botanix Q4 FY26 Investor Update Webinar Presentation 27 Jul 2026 9:15AM $0.023 $0.014 fallen by 39.13%
$39 Botanix Quarterly Activities Report and Appendix 4C Q4 FY26 27 Jul 2026 9:12AM $0.023 $0.014 fallen by 39.13%
$39 Botanix Webinar on 27 July - Registration Information 20 Jul 2026 9:08AM $0.025 $0.014 fallen by 44%
$39 Notice of Allowance for US patent on Sofdra drug substance 13 Jul 2026 9:13AM $0.024 $0.014 fallen by 41.67%
$39 Intention to Grant a European patent on Sofdra applicator 7 Jul 2026 9:14AM $0.022 $0.014 fallen by 36.36%
$39 Application for quotation of securities - BOT 25 May 2026 11:57AM $0.025 $0.014 fallen by 44%
$39 Notification of cessation of securities - BOT 21 May 2026 5:27PM $0.025 $0.014 fallen by 44%
$39 Application for quotation of securities - BOT 13 May 2026 5:13PM $0.030 $0.014 fallen by 53.33%
$39 Securities Trading Policy 8 May 2026 4:46PM $0.027 $0.014 fallen by 48.15%
$39 Botanix announces change of address 6 May 2026 5:34PM $0.025 $0.014 fallen by 44%
$39 Botanix appoints Chief Operating Officer 4 May 2026 9:06AM $0.027 $0.014 fallen by 48.15%
$39 Botanix Q3 FY26 Investor Update Webinar Presentation 29 Apr 2026 8:53AM $0.030 $0.014 fallen by 53.33%
$39 Botanix Quarterly Activities Report and Appendix 4C Q3 FY26 29 Apr 2026 8:50AM $0.030 $0.014 fallen by 53.33%
$39 Change of Director's Interest Notice x5 24 Apr 2026 1:10PM $0.033 $0.014 fallen by 56.92%

1 - 25 of 716 results

Page 1 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.